The global antibody therapeutics market is experiencing a period of substantial growth. This trend can be attributed to several factors, including the increasing prevalence of chronic diseases, advancements in biotechnology, and growing acceptance of biologics. The market is forecast to expand at a CAGR of Z% during the forecast period, driven by f